Document and Entity Information Statement [Table] Statement [Line Items] Statement Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Current Reporting Status Entity Filer Category Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Period Focus CONSOLIDATED BALANCE SHEETS Assets [Abstract] ASSETS Assets, Current [Abstract] CURRENT ASSETS: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents at the end of the period Cash and cash equivalents at the beginning of the period Cash and cash equivalents Restricted Cash and Cash Equivalents, Current Restricted cash Prepaid Expense and Other Assets, Current Other accounts receivable and prepaid expenses Assets, Current Total current assets Deposits Assets, Noncurrent LONG-TERM LEASE DEPOSIT Assets Held-in-trust, Noncurrent SEVERANCE PAY FUND Property, Plant and Equipment, Net PROPERTY AND EQUIPMENT, NET Assets Total assets Liabilities and Equity [Abstract] LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT) Liabilities, Current [Abstract] CURRENT LIABILITIES: Accounts Payable, Trade, Current Trade payables Long-term Debt, Current Maturities Current maturity of loan Deferred Revenue, Current Deferred revenues Accounts Payable and Accrued Liabilities, Current Other accounts payable and accrued expenses Liabilities, Current Total current liabilities Liabilities, Noncurrent [Abstract] NON-CURRENT LIABILITIES: Deferred Revenue, Noncurrent Deferred revenues Postemployment Benefits Liability, Noncurrent Accrued severance pay Accounts Payable and Accrued Liabilities, Noncurrent Other accounts payable Liabilities, Noncurrent Total non-current liabilities Commitments and Contingencies. COMMITMENTS AND CONTINGENT LIABILITIES Stockholders' Equity Attributable to Parent [Abstract] STOCKHOLDERS' EQUITY (DEFICIT): Common Stock, Value, Issued Ordinary Shares of NIS 0.01 par value - Authorized: 50,000,000 at December 31, 2015 and March 31, 2016, respectively; Issued and outstanding: 13,585,810 at December 31, 2015 and March 31, 2016, respectively Additional Paid in Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Stockholders' Equity Attributable to Parent Balance, ending Balance, beginning Total shareholders' equity Liabilities and Equity Total liabilities and shareholders' equity Ordinary Shares Disclosures Common Stock, Par or Stated Value Per Share Ordinary Shares, par value per share Common Stock, Shares Authorized Ordinary Shares, shares authorized Common Stock, Shares, Issued Ordinary Shares, shares issued Common Stock, Shares, Outstanding Ordinary Shares, shares outstanding CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Revenues Licensing Revenues Operating Expenses [Abstract] Operating expenses: Research and Development Expense Research and development Marketing Expense Marketing General and Administrative Expense General and administrative Operating Expenses Total operating expenses: Operating Income (Loss) Total operating loss Nonoperating Income (Expense) Financial income, net Financial income, net Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest Loss before taxes on income Income Tax Expense (Benefit) Taxes on income Net Income (Loss) Attributable to Parent Net loss Net loss Net loss Net loss Earnings Per Share [Abstract] Net loss per share: Earnings per share Income (Loss) from Continuing Operations, Per Basic and Diluted Share Basic and diluted net loss per Ordinary Share Weighted Average Number of Shares Outstanding, Basic and Diluted Weighted average number of Ordinary Shares used in computing basic and diluted net loss per share Weighted average number of Ordinary Shares used in computing basic and diluted net loss per share STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY DEFICIT Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Common Stock [Member] Ordinary Shares Additional Paid In Capital [Member] Additional paid-in capital Retained Earnings [Member] Accumulated deficit Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (decrease) in Stockholders' Equity Shares, Issued Balance, ending (in shares) Balance, beginning (in shares) Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Stock-based compensation CONSOLIDATED STATEMENT OF CASH FLOWS Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Cash flows from operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments required to reconcile net loss to net cash used in operating activities: Share-based Compensation Stock-based compensation Depreciation, Depletion and Amortization Depreciation The net amount of noncash accrued severance which is an add back when calculating net cash generated by operating activities using the indirect method. Accrued Severance Pay, Net, Noncash Addback Accrued severance pay, net Amortization of Debt Discount (Premium) Amortization of discount on loan Fair Value Adjustment of Warrants Revaluation of fair value of warrants to purchase Convertible Preferred Shares Increase (Decrease) in Prepaid Expense and Other Assets Increase in other accounts receivable and prepaid expenses Increase (Decrease) in Deferred Revenue Decrease in deferred revenues Increase (Decrease) in Accounts Payable, Trade Increase (decrease) in trade payables Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Increase in other accounts payable and accrued expenses Net Cash Provided by (Used in) Operating Activities, Continuing Operations Negative cash flows from operating activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Cash flows from investing activities: Proceeds from Sale of Restricted Investments Proceeds from maturity of investment in restricted cash Payments to Acquire Property, Plant, and Equipment Purchase of property and equipment Net Cash Provided by (Used in) Investing Activities, Continuing Operations Net cash used in investing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Cash flows from financing activities: Sale of Stock, Consideration Received on Transaction Proceeds from issuance of Ordinary Shares, net of issuance costs upon IPO Proceeds from Issuance of Convertible Preferred Stock Proceeds from issuance of convertible preferred shares Repayments of Long-term Debt Repayment of loan Proceeds from Stock Options Exercised Proceeds from exercise of options into Ordinary Shares Net Cash Provided by (Used in) Financing Activities, Continuing Operations Net cash (used in) provided by financing activities Net Cash Provided by (Used in) Continuing Operations Net increase (decrease) in cash and cash equivalents Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental disclosure of non-cash investing and financing activities: Capital Expenditures Incurred but Not yet Paid Purchase of property and equipment Conversion of Stock, Amount Converted Conversion of Convertible Preferred Shares into Ordinary Shares Conversion of Warrants to Purchase Convertible Preferred Shares into Ordinary Shares. Conversion of Warrants to Purchase Convertible Preferred Shares into Ordinary Shares Conversion of Warrants to purchase Convertible Preferred Shares into Ordinary Shares Non-cash deferred IPO Costs Noncash Deferred IPO Costs Non-cash deferred IPO costs Conversion of Warrants to purchase Convertible Preferred Shares into Warrants to purchase Ordinary Shares Conversion of Warrants to Purchase Convertible Preferred Shares into Warrants to Purchase Ordinary Shares Conversion of Warrants to purchase Convertible Preferred Shares into Warrants to purchase Ordinary Shares Supplemental Cash Flow Information [Abstract] Cash paid during the year: Interest Paid, Net Interest Income Taxes Paid, Net Taxes on income GENERAL Nature of Operations [Abstract] GENERAL no definition UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS Basis of Accounting [Text Block] UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] SIGNIFICANT ACCOUNTING POLICIES LOAN Long-term Debt [Text Block] LOAN COMMITMENTS AND CONTINGENT LIABILITIES Commitments and Contingencies Disclosure [Text Block] COMMITMENTS AND CONTINGENT LIABILITIES SHAREHOLDERS' EQUITY Shareholders' Equity and Share-based Payments [Text Block] SHAREHOLDERS' EQUITY SELECTED STATEMENTS OF COMPREHENSIVE LOSS Additional Financial Information Disclosure [Text Block] SELECTED STATEMENTS OF COMPREHENSIVE LOSS Schedule of Stock Options Roll Forward [Table Text Block] Schedule of stock options roll forward Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Schedule of total compensation cost related to all of the Company's equity-based awards Schedule of Other Nonoperating Income (Expense) [Table Text Block] Schedule of financial income, net Schedule of Weighted Average Number of Shares [Table Text Block] Schedule of weighted average number of shares The disclosure of organization information. Organization Disclosures [Table] Not available Organization Disclosures [Line Items] The number of products the company is developing. Number Of Products In Development Number of products in development Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary, Sale of Stock [Axis] Sale Of Stock Name Of Transaction [Domain] Sale of Stock, Name of Transaction [Domain] I P O [Member] IPO Subsidiary, Sale of Stock [Line Items] Initial Public Offering Stock Issued During Period, Shares, New Issues Common stock issued (in shares) Issuance of Ordinary Shares, upon IPO (in shares) Price per share Issuance of Ordinary Shares, net of issuance costs of $5,256, upon IPO Aggregate net proceeds received from IPO offering, net of underwriting discounts and commissions and offering expenses Share amount of issuance of Ordinary Shares, net of underwriters? fees Issuance of Ordinary Shares, net of underwriters fees (in shares) Issuance of Ordinary Shares, net of underwriters' fees (in shares) The cash inflow from issuance of Ordinary Shares, net of underwriters' fees. Proceeds From Issuance of Ordinary Shares, Net of Underwriters' Fees Proceeds from issuance of Ordinary Shares, net of underwriters' fees Stock Issued During Period, Shares, Conversion of Convertible Securities Conversion of Convertible Preferred Shares into Ordinary Shares upon IPO (in shares) No definition available. Warrants Disclosures [Abstract] Warrants Disclosures Class of Warrant or Right, Outstanding Warrants outstanding (in shares) The number of warrants for Convertible Preferred Shares exercised for cash. Warrants For Convertible Preferred Shares Exercised For Cas Number of Warrants for Convertible Preferred Shares exercised for cash (in shares) The number of warrants for Convertible Preferred Shares exercised on a cashless basis. Warrants For Convertible Preferred Shares Exercised On Cashless Basis Number of Warrants for Convertible Preferred Shares exercised on cashless basis (in shares) The net number of warrants for Convertible Preferred Shares exercised. Net Warrants For Convertible Preferred Shares Exercised Net number of Warrants for Convertible Preferred Shares exercised (in shares) The number of warrants for Convertible Preferred Shares that were cancelled. Warrants For Convertible Preferred Shares Cancelled Number of Warrants for Convertible Preferred Shares cancelled (in shares) The number of warrants for Convertible Preferred Shares that were automatically converted into warrants for Ordinary Shares. Warrants For Convertible Preferred Shares Automatically Converted Into Warrants For Ordinary Shares Number of Warrants for Convertible Preferred Shares automatically converted into warrants for Ordinary Shares (in shares) Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table] Counterparty Name [Axis] Repurchase Agreement Counterparty Name [Domain] Counterparty Name [Domain] Information pertaining to Cardiome Pharma Corp. and Correvio International Sarl (collectively referred to as "Cardiome"). Cardiome Pharma Corp And Correvio International Sarl [Member] Cardiome Type of Arrangement and Non-arrangement Transactions [Axis] Arrangements And Nonarrangement Transactions [Member] Arrangements and Non-arrangement Transactions [Domain] Collaborative Arrangement [Member] Collaboration Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] License and supply agreement Upfront payment provided for per license agreement. Upfront Payment Provided For Per License Agreement Upfront payment provided for per license agreement Represents the aggregate maximum milestone payments to be achieved by the counterparty per the license agreement. Collaborative Arrangement Milestone Payments Aggregate Maximum Aggregate maximum milestone payments to be achieved per agreement The low end of the range of tiered royalty percentages to be applied per license agreement. Collaborative Arrangement Scaling Royalties Percentage Low End Of The Range Scaling royalty percentage, low end of range The high end of the range of tiered royalty percentages to be applied per license agreement. Collaborative Arrangement Scaling Royalties Percentage High End Of Range Scaling royalty percentage, high end of range Schedule of Long-term Debt Instruments [Table] Commercial Bank with whom the entity entered into debt agreement Commercial Bank [Member] Bank Debt Instrument [Axis] Debt Instrument Name [Domain] Debt Instrument, Name [Domain] Represents the information pertains to borrowings under the Loan Agreement. Loan Agreement [Member] Loan Agreement Class of Stock [Axis] Class Of Stock [Domain] Class of Stock [Domain] Series D Preferred Stock [Member] Series D Preferred shares Debt Instrument [Line Items] Loan Proceeds from Bank Debt Amount borrowed Debt Instrument, Interest Rate, Stated Percentage Rate Range, Minimum Minimum variable annual rate Debt Instrument, Description of Variable Rate Basis Variable rate basis Debt Instrument, Basis Spread on Variable Rate Basis spread on variable rate Represents the number of equal installments the debt is to be repaid. Debt Instrument Number Of Installments For Repayment Number of installments for repayment Represents the minimum percentage of outstanding loan principal to be maintained as cash balance through maturity date of the loan Minimum Percentage Of Outstanding Loan Principal To Be Maintained As Cash Balance Minimum percentage of outstanding loan principal to be maintained as cash balance Represents the percentage of the aggregate amount of consolidated entities' cash to be held by entity that signed the debt agreement. Percentage Of Aggregate Amount Of Consolidated Entities' Cash To Be Held By Entity That Signed Debt Agreement Percentage of aggregate amount of cash of consolidated entities to be held by entity that signed debt agreement Represents the numbers of warrants issued to purchase convertible preferred stock. Warrants Or Rights Issued To Purchase Convertible Preferred Stock Warrants issued to purchase preferred stock Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price of warrant Represents the expiration term of warrants or rights. Warrants Or Rights Expiration Term Expiration term of warrants Schedule of Operating Leased Assets [Table] Geographical [Axis] Segment Geographical [Domain] Geographical [Domain] I [L] Israel San Ramon, California. San Ramon California [Member] San Ramon, California Operating Leased Assets [Line Items] Operating leases Leases, Operating [Abstract] Operating lease agreement Lessee Leasing Arrangements, Operating Leases, Term of Contract Lease term Lessee Leasing Arrangements, Operating Leases, Renewal Term Lease extension term Additional term of the lessee's leasing arrangements per option exercised, in 'PnYnMnDTnHnMnS' format. Lessee, Leasing Arrangements, Operating Lease, Option Exercised, Lease Term Additional lease extension term per option exercised Other Commitments [Table] Range [Axis] Range [Member] Range [Domain] Minimum [Member] Minimum Maximum [Member] Maximum Information pertaining to the combination of the Office of the Chief Scientist (the "OCS") and the Incubator, Rad Biomed Ltd. Combined Office Of Chief Scientist And Incubator Rad Biomed Ltd [Member] Combined OCS and Incubator, RAD Biomed Ltd Information pertaining to the Office of the Chief Scientist (the "OCS"). Office Of Chief Scientist [Member] OCS Other Commitments [Line Items] Other commitments No definition available. Royalties [Abstract] Royalties Represents the percentage of royalties committed to pay on future revenues. Percentage Of Royalty Commitments On Future Revenues Royalties commitment on future revenues (as a percent)